SPECIAL NOTICE
99 -- Intent to Sole Source - Clinical Hand Transplant Program
- Notice Date
- 3/23/2011
- Notice Type
- Special Notice
- NAICS
- 541712
— Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Contracting Office
- N62645 Naval Medical Logistics Command 693 Neiman Street Ft. Detrick, MD
- ZIP Code
- 00000
- Solicitation Number
- N6264511WM001
- Archive Date
- 5/8/2011
- E-Mail Address
-
NMLC Research
(NMLC-Research@med.navy.mil)
- Small Business Set-Aside
- N/A
- Description
- The Naval Medical Logistics Command intends to award a sole source contract under the authority of FAR 6.302-1 to Emory University, 201 Dowman Drive, Atlanta, GA 30322, for the performance of research and development (R&D), preclinical and clinical studies in support of the Naval Medical Research Center. This requirement will establish a research and development capability to address the Joint Force Protection Research Gap œInadequate definitive, restorative, and rehabilitative medical care and surgery for life- and limb- and eyesight-saving actions. The goal of this requirement is to develop an immune suppression strategy that limits adverse effects of immune suppression and enhance long-term graft survival. Studies will include preclinical and clinical work to include mechanistic studies that will be conducted in rodents. The translational research of new treatment combinations will be tested in non-human primates (NHPs). The estimated value of the contract is $1.8 Million and the period of performance will be up to 18 months. This effort will complement a previous collaboration between the Regenerative Medicine Department of the Naval Medical Research Center and Emory University on the development of tolerance induction strategies for composite tissue transplantation and a clinical hand transplant program. Under a prior award Emory University was able to establish the logistical support for the clinical protocol to conduct hand transplants, identified and enrolled the initial patients to be recipients. Emory has also identified an immunosuppression strategy based on non-human primate (NHP) studies completed under the prior award. Emory University possesses a unique comprehensive multidisciplinary composite tissue allotransplantation (CTA) research program. The university has the capability to transition treatment protocols from the basic laboratory to the clinic and back to the laboratory to efficiently improve the applications of composite tissue allotransplantation. To date, the team at Emory University holds the largest experience reported in the scientific literature in CTA in NHPs. The clinical studies will leverage the considerable scientific support afforded by the Emory Transplant Center. In addition, the transplant program at Emory is the only one in the United States with an established composite tissue allotransplantation at a United States Veterans Affairs (VA) hospital and is therefore uniquely positioned to offer this experimental therapy to active duty service members as well as veterans. Based on these unique capabilities and the previous work done with the Emory Transplant Center, Emory University is the only institution capable of meeting the Government ™s requirements. This Notice of Intent is not a request for competitive proposals and no solicitation document exists for this requirement. However, parties interested in responding to this notice will need to submit technical data and other information sufficient to determine capability to perform the proposed contract effort. All capability statements received by 2:00 PM Eastern Time on April 8, 2011 will be considered by the Government. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Capability statements shall be submitted by email ONLY as a Microsoft Word or Adobe PDF attachment to NMLC-Research@med.navy.mil.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/DON/BUMED/N62645/N6264511WM001/listing.html)
- Record
- SN02407640-W 20110325/110323234603-3b468d67d499e450fe29b00ad2ced441 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |